Estrogen, not intrinsic aging, is the major regulator of delayed human wound healing in the elderly by Hardman, Matthew J & Ashcroft, Gillian S
Genome Biology 2008, 9:R80
Open Access 2008 Hardman and Ashcroft Volume 9, Issue 5, Article R80 Research
Estrogen, not intrinsic aging, is the major regulator of delayed 
human wound healing in the elderly
Matthew J Hardman and Gillian S Ashcroft
Address: Faculty of Life Sciences, University of Manchester, Oxford Road, Manchester M13 9PT, UK. 
Correspondence: Matthew J Hardman. Email: matthew.j.hardman@manchester.ac.uk. Gillian S Ashcroft. Email: 
gillian.s.ashcroft@manchester.ac.uk
© 2008 Hardman and Ashcroft; licensee BioMed Central Ltd. 
This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which 
permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
The role of estrogen in wound healing <p>Analysis of gene expression in male elderly and young human wounds suggests that estrogen has a more profound influence on aging  than previously thought.</p>
Abstract
Background: Multiple processes have been implicated in age-related delayed healing, including
altered gene expression, intrinsic cellular changes, and changes in extracellular milieu (including
hormones). To date, little attempt has been made to assess the relative contribution of each of
these processes to a human aging phenomenon. The objective of this study is to determine the
contribution of estrogen versus aging in age-associated delayed human wound healing.
Results: Using an Affymetrix microarray-based approach we show that the differences in gene
expression between male elderly and young human wounds are almost exclusively estrogen
regulated. Expression of 78 probe sets was significantly decreased and 10 probe sets increased in
wounds from elderly subjects (with a fold change greater than 7). A total of 83% of down-regulated
probe sets and 80% of up-regulated probe sets were estrogen-regulated. Differentially regulated
genes were validated at the level of gene and protein expression, with genes identified as estrogen-
regulated in human confirmed as estrogen-dependent in young estrogen depleted mice in vivo.
Moreover, direct estrogen regulation is demonstrated for three array-identified genes, Sele, Lypd3
and Arg1, in mouse cells in vitro.
Conclusion:  These findings have clear implications for our understanding of age-associated
cellular changes in the context of wound healing, the latter acting as a paradigm for other age-
related repair and maintenance processes, and suggest estrogen has a more profound influence on
aging than previously thought.
Background
In elderly subjects wound healing is severely impaired,
accompanied by substantial morbidity, mortality and an esti-
mated cost to health services of over $15 billion per annum in
the US alone. A unified theory of biological aging is emerging
in which cellular maintenance and repair systems are influ-
enced by genes and environment, and wound healing is one of
the main pathways of such repair responses [1]. Hormones
are potential determining factors in the aging process, and
estrogen has been shown to be beneficial in accelerating the
age-related impaired tissue repair response in the skin of both
genders [2,3]. Elderly male subjects have the highest inci-
dence of chronic non-healing wounds [4,5], correlating with
reduced local levels of the beneficial hormone estrogen, with
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relative maintenance of the androgen hormones that are det-
rimental to healing [6]. Thus, estrogen has been viewed as a
piece of the complex jigsaw modulating aging repair proc-
esses. Multiple processes have been implicated in cutaneous
aging, including gene expression, intrinsic cellular change
and an altered extracellular milieu. However, the relative
contribution of each of these processes to age-associated
delayed healing is unknown. Here at the level of gene expres-
sion, we provide novel insight into the relative contribution of
hormones and intrinsic aging, including gerontogenes, to
delayed wound healing.
There exists a substantial body of research addressing the tis-
sue, cellular and molecular changes that accompany or
directly contribute to aging in a range of model organisms
(reviewed in [7]). However, the majority of data, generated in
model organisms or in vitro (cellular senescence), has yet to
be validated in human aging. Moreover the relative contribu-
tion of putative gerontogenes to human pathological age-
related processes is unknown. Age-associated impaired heal-
ing correlates with increased inflammation, increased matrix
proteolysis and delayed re-epithelialization leading to
chronic wound states, processes modulated by exogenous
estrogen treatment [8]. In a recent study we characterized
estrogen-regulated changes in gene expression using a model
of delayed wound healing in young mice that have been ren-
dered hypogonadal by ovariectomization (hence removing
any effects of 'intrinsic aging') [9]. Thus, using comparative
analysis we are now in a position to address the relative con-
tributions of estrogen and aging to healing in elderly humans.
Since the major variable contributing to chronic wounds in
humans is being an aged male [4,5], our initial approach was
to compare acute wound gene expression between young and
old male human subjects via Affymetrix microarray. We used
the principle of data mining for gene enrichment [10] fol-
lowed by a cross-species comparison to our recently pub-
lished dataset of mouse wound estrogen-regulated genes [9]
and interrogation of the Dragon online database of estrogen-
regulated genes [11] combined with manual annotation to
identify estrogen regulated probe sets. Androgen levels,
which inhibit healing, are relatively well-maintained in eld-
erly males (data not shown), thus the potential effects are
cancelled out when comparing males of different ages. Puta-
tive-gerontogenes and genes with established aging-related
functions were identified by interrogation of the GenAge
online database [12], from aging-associated Gene Ontology
(GO) groups and from hand annotation (see Materials and
methods/Results for a detailed description of the analysis).
We show that the fundamental changes in genes and proc-
esses linked to the pathophysiology of age-related delayed
healing in humans appear to be almost exclusively estrogen
regulated. Estrogen exerts its effects by down-regulating a
variety of genes associated with regeneration, matrix produc-
tion, protease inhibition and epidermal function and up-reg-
ulating genes primarily associated with inflammation. These
findings have clear implications for our understanding of age-
associated cellular changes in the context of wound healing,
and are highly relevant with respect to many other age-
related repair and maintenance processes.
Results and discussion
We initially used immunohistochemical analysis to deter-
mine and compare the temporal profile of cellular change in
wounds from young and elderly males (Figure 1). We
observed clear age-dependent differences in wound numbers
of inflammatory cells (neutrophils and macrophages) and
rate of re-epithelialization early in healing (three days post-
wounding; D3) and fibroblasts/blood vessels during the tis-
sue remodeling phase (three months post-wounding; 3Mo).
Crucially, we identified seven days post-wounding (D7) as a
period where in males wound cellular composition is equiva-
lent in both young and elderly subjects. This finding facili-
tated subsequent microarray analysis of wound gene
expression by eliminating the possibility of changes in gene
expression arising due to disproportionate representation of
a specific cell type between biological samples. Hence,
changes identified are the result of actual changes in wound
gene expression.
For the purpose of this study, probe sets showing significant
differential regulation between young and old human wounds
were identified by filtering for a fold change of ±7-fold, a q-
value <0.1 and expression level >15 (see Additional data file 1
for the full list of identified probe sets; 10 up-regulated and 78
down-regulated). We then used a combination of sources to
identify estrogen-regulated genes. We exploited the Dragon
online database [11] to assemble a subset of estrogen-regu-
lated genes (subset S1; Additional data file 2). We re-analyzed
our own recently published mouse estrogen-regulated gene
data set [9] (see Materials and methods) and through com-
parative analysis identified a gene subset conserved between
human and mouse (subset S2; Additional data file 3). A third
subset was compiled through hand annotation (subset S3;
Additional data file 4). The vast majority of differentially
expressed genes were estrogen-regulated (Table 1, Figure 2)
and most were down-regulated in wounds from elderly sub-
jects. Using a binomial distribution calculation we deter-
mined that our enriched data set contained many more
estrogen-regulated genes than would be expected to arise by
chance (Dragon: observed = 20, expected = 9.3, p = 0.0002;
and Mouse data set: observed = 19, expected = 3.8, p = 0.0).
Down-regulated estrogen-regulated genes were highly
enriched for epidermal GO groups, such as epidermal devel-
opment (EASE p = 2.7E-16; Figure 2; Additional data file 5).
We observed a strong reduction in epidermal differentiation-
associated genes, particularly those encoding cornified enve-
lope proteins (8 genes; EASE p = 0.00027), such as LOR
(235-fold reduction) and FLG (114-fold reduction), suggest-
ing a delay in barrier formation. Within hours of injuryhttp://genomebiology.com/2008/9/5/R80 Genome Biology 2008,     Volume 9, Issue 5, Article R80       Hardman and Ashcroft  R80.3
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epithelial cells are mobilized to restore tissue functional
integrity. Multiple genes associated with these specific proc-
esses are strongly down-regulate d i n w ou n ds f ro m e lde rly
subjects (Table 1). These include the hyperproliferation-asso-
ciated keratin, KRT16 (8.3-fold reduction) and LYPD3 (9.7-
fold reduction), a uPAR homologue that is up-regulated in
migrating keratinocytes. These findings correlate with the
observation that aged keratinocytes show a depressed migra-
tory capacity compared to young cells in a wound environ-
ment [13]. Indeed, in wounds from both elderly humans and
ovariectomised (ovx) mice re-epithelialization is attenuated
(Figure 1) [2,14] and can be restored by topical or systemic
Temporal profile of changes in wound cellular composition Figure 1
Temporal profile of changes in wound cellular composition. (a) Total granulation tissue cell numbers increase over time with no difference between young 
and old male subjects prior to three months. Closer examination reveals that the inflammatory cell profiles for (b) neutrophils and (c) macrophages differ 
significantly at day 3 (D3) post-wounding. (d) Differential re-epithelialization is also apparent at this time-point (D3). (e,f) In contrast, fibroblast and blood 
vessel numbers are increased in wounds from elderly subjects at the three month (3Mo) time point. Note equivalent numbers of each cell type in young 
and old wounds at D7 (red highlight), the time-point chosen for this study. (g-j) Comparative images for total cell (hematoxylin and eosin; g), neutrophil 
(CD15; h) macrophage (CD68; i) and endothelial cell (VWF; j) immunostaining. The scale bar in (j) represents 50 μm (g), 20 μm (h), 35 μm (i), and 45 μm 
(j).
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Table 1
Estrogen-regulated probe sets that are differentially expressed in wounds from elderly compared to young subjects
Affy ID Gene* Gene (description) Function q-value† FC‡
Down-regulated probe sets (65)
207720_at LOR loricrin Major cornified envelope protein 0 -235
201909_at RPS4Y1 ribosomal protein S4, Y-linked 1 40S ribosomal component 0 -142
215704_at FLG filaggrin Cornified envelope-keratin linker 9.4E-13 -114
206177_s_at ARG1 arginase, liver Delayed healing-associated 9.2E-11 -82.0
206643_at HAL histidine ammonia-lyase Histidine catabolism 1.5E-10 -59.0
206421_s_at SERPINB7 serpin peptidase inhibitor, clade B 
(ovalbumin), member 7
Proteinase inhibitor for plasmin 5.9E-13 -47.6
206192_at CDSN Corneodesmosin Desquamation/adhesion 2.5E-06 -30.1
213796_at SPRR1A small proline-rich protein 1A Cornified envelope precursor 
protein
1.5E-05 -29.4
207324_s_at DSC1 desmocollin 1 Desmosomal cadherin/adhesion 9.6E-06 -28.9
209719_x_at SERPINB3 serpin peptidase inhibitor, clade B 
(ovalbumin), member 3
Inflammation and cancer-associated 1.6E-05 -22.4
217496_s_at IDE insulin-degrading enzyme Wound fluid/resolution of insulin 
response
4.0E-06 -20.5
211597_s_at HOP homeodomain-only protein Serum response factor binding 1.7E-04 -19.7
211726_s_at FMO2 flavin containing monooxygenase 2 
(non-functional)
Non-functional oxidative enzyme 7.0E-04 -18.9
220414_at CALML5 calmodulin-like 5 Epidermal-associated calcium-binding 2.0E-05 -17.7
203328_x_at IDE insulin-degrading enzyme Wound fluid/resolution of insulin 
response
1.4E-05 -17.4
210413_x_at SERPINB4 serpin peptidase inhibitor, clade B 
(ovalbumin), member 4
Cancer and inflammation-associated 3.1E-05 -15.8
219795_at SLC6A14 solute carrier family 6 (amino acid 
transporter), member 14
Amino acid transport/obesity 6.9E-04 -15.6
210074_at CTSL2 cathepsin L2 Lysosomal cysteine proteinase 3.8E-05 -15.5
222242_s_at KLK5 kallikrein 5 Desquamation, angiogenesis and 
cancer
4.0E-05 -15.0
201348_at GPX3 glutathione peroxidase 3 (plasma) Protection from oxidative damage 1.2E-05 -14.8
202018_s_at LTF lactotransferrin Inflammatory-cell-derived 
antioxidant
4.6E-02 -14.5
205185_at SPINK5 serine peptidase inhibitor, Kazal type 
5
Anti-inflammatory/anti-microbial 3.8E-05 -14.4
211906_s_at SERPINB4 serpin peptidase inhibitor, clade B 
(ovalbumin), member 4
Cancer and inflammation-associated 5.7E-05 -12.4
219232_s_at EGLN3 egl nine homolog 3 (C. elegans) Hypoxia-inducible apoptosis-inducing 1.4E-05 -12.1
213256_at MARCH3 membrane-associated ring finger 
(C3HC4) 3
Poorly characterized ubiquitin ligase 1.6E-05 -12.1
204733_at KLK6 kallikrein 6 (neurosin, zyme) Hormone regulated serine protease 1.4E-05 -11.9
202179_at BLMH bleomycin hydrolase Cysteine peptidase 2.1E-03 -11.8
214549_x_at SPRR1A small proline-rich protein 1A Cornified envelope precursor 
protein
1.6E-04 -11.3
207908_at KRT2 keratin 2 (epidermal ichthyosis 
bullosa of Siemens)
Supra-basally expressed cytokeratin 1.2E-03 -11.1
210338_s_at HSPA8 heat shock 70 kDa protein 8 ERalpha-inhibiting heat shock protein 9.9E-04 -10.6
209720_s_at SERPINB3 serpin peptidase inhibitor, clade B 
(ovalbumin), member 3
Inflammation and cancer-associated 3.3E-04 -10.5
201849_at BNIP3 BCL2/adenovirus E1B 19 kDa 
interacting protein 3
Mitochondrial apoptosis-inducing 2.7E-04 -10.1
205916_at S100A7 S100 calcium binding protein A7 Chemotactic psoriasis-associated 
protein
1.7E-04 -10.0http://genomebiology.com/2008/9/5/R80 Genome Biology 2008,     Volume 9, Issue 5, Article R80       Hardman and Ashcroft  R80.5
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204952_at LYPD3 LY6/PLAUR domain containing 3 Upregulated in migrating 
keratinocytes
1.2E-03 -9.7
206595_at CST6 cystatin E/M Cysteine protease inhibitor 1.7E-06 -9.3
203327_at IDE insulin-degrading enzyme Wound fluid/resolution of insulin 
response
7.0E-04 -9.3
209555_s_at CD36 CD36 molecule Thrombospondin receptor 4.0E-03 -9.2
219532_at ELOVL4 elongation of very long chain fatty 
acids (FEN1/Elo2, SUR4/Elo3, yeast)-
like 4
Skin barrier-promoting fatty acid 
elongase
1.5E-05 -9.2
209126_x_at KRT6B keratin 6B Injury-associated keratin 1.7E-03 -9.1
212573_at ENDOD1 endonuclease domain containing 1 Unknown 8.3E-04 -9.0
214599_at IVL involucrin Early cornified envelope protein 2.8E-03 -8.8
209218_at SQLE squalene epoxidase Rate-limiting sterol biosynthesis 
enzyme
7.2E-04 -8.8
207356_at DEFB4 defensin, beta 4 Antimicrobial peptide 6.0E-03 -8.8
210138_at RGS20 regulator of G-protein signaling 20 GTPase-activating protein 8.1E-04 -8.7
202504_at TRIM29 tripartite motif-containing 29 Cancer-associated transcription 
factor
2.2E-03 -8.6
205016_at TGFA transforming growth factor, alpha IFN-induced/epidermal regeneration 1.0E-03 -8.5
209309_at AZGP1 alpha-2-glycoprotein 1, zinc TNFA-regulated prostate-cancer 
marker
3.5E-04 -8.5
209800_at KRT16 keratin 16 (focal non-epidermolytic 
palmoplantar keratoderma)
Hyperproliferation and healing-
associated keratin
1.2E-03 -8.3
205778_at KLK7 kallikrein 7 (chymotryptic, stratum 
corneum)
Innate immunity/desquamation 1.2E-05 -8.3
219756_s_at POF1B premature ovarian failure, 1B Unknown 3.9E-05 -8.1
214091_s_at GPX3 glutathione peroxidase 3 (plasma) Protection from oxidative damage 3.0E-03 -8.1
203585_at ZNF185 zinc finger protein 185 (LIM domain) Actin-associated tumor suppressor 1.4E-03 -8.1
206008_at TGM1 transglutaminase 1 CE formation/epidermal 
differentiation
4.6E-05 -8.0
202037_s_at SFRP1 secreted frizzled-related protein 1 Repressor of WNT signaling 6.6E-04 -7.9
202539_s_at HMGCR 3-hydroxy-3-methylglutaryl-
Coenzyme A reductase
Rate-limiting cholesterol synthesis 
enzyme
7.4E-04 -7.8
203575_at CSNK2A2 casein kinase 2, alpha prime 
polypeptide
p53 phosphorylation, WNT signaling 4.6E-04 -7.7
206884_s_at SCEL sciellin Cornified envelope precursor 
protein
2.1E-04 -7.5
204284_at PPP1R3C protein phosphatase 1, regulatory 
(inhibitor) subunit 3C
Regulates a wide variety of cellular 
functions
9.9E-04 -7.4
266_s_at CD24 CD24 molecule Marker for epithelial neoplasms 2.7E-04 -7.4
203914_x_at HPGD hydroxyprostaglandin dehydrogenase 
15-(NAD)
Main enzyme for prostaglandin 
degradation
1.6E-04 -7.3
219410_at TMEM45A transmembrane protein 45A Hox-regulated/reproductive tissue 
expressed
8.1E-04 -7.3
206488_s_at CD36 CD36 molecule Thrombospondin receptor 1.2E-05 -7.3
204881_s_at UGCG UDP-glucose ceramide 
glucosyltransferase
Keratinocyte glucosyltransferase 1.8E-03 -7.1
213933_at PTGER3 prostaglandin E receptor 3 (subtype 
EP3)
Impaired wound healing in null 
mouse
8.3E-04 -7.1
216379_x_at CD24 CD24 molecule Marker for epithelial neoplasms 7.9E-04 -7.0
Up-regulated probe sets (8)
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estrogen [2,3]. Our data uniquely identify novel gene targets
involved in this process.
It has been suggested that delayed wound healing in the eld-
erly results from an imbalance between wound proteases and
protease inhibitors, the net result of which is tissue break-
down [8]. Here we demonstrate coordinate changes in
expression of estrogen-regulated protease inhibitor encoding
genes, including members of the SERPIN family (six probe
sets) and cystatin E/M (CST6), which act to protect against
inappropriate activation of cathepsins. This suggests that
delayed-healing wounds are in a profound state of protease
inhibitor deprivation (EASE p = 0.0038). Novel wound heal-
ing genes with dramatic fold differences include SERPINB7,
which is 47-fold down-regulated in wounds from elderly sub-
jects, and has only previously been reported in the kidney
associated with extracellular matrix overexpression [15], and
SERPINB4 (17-fold down-regulated), the expression of which
has, to our knowledge, never been reported in the skin. Skin
expression of these novel SERPIN genes is supported by a
very high number of skin-derived expressed sequence tags. In
this regard, a number of anti-inflammatory, anti-oxidant,
and/or anti-microbial genes are also down-regulated in
wounds from elderly subjects, such as the antimicrobial pep-
tide defensin beta 4 (DEFB4; 8.8-fold), lactoferrin (LTF; 14.5-
fold), an interesting molecule with antibacterial, antimycotic,
antiviral, and anti-inflammatory activity, and secretory leu-
kocyte protease inhibitor (SLPI; 5.3-fold), which antagonizes
human neutrophil elastase, preventing tissue injury resulting
from excessive proteolysis, in addition to possessing broad
antimicrobial activity. In Slpi null mice increased leukocyte
elastase levels lead to severely delayed wound healing with
similarities to human chronic wound states [16].
In concordance with the pro-inflammatory aging state, not
only is 'inflammatory response' the major GO group overrep-
resented in the list of genes up-regulated in delayed-healing
wounds from elderly subjects (EASE p  = 0.056), but the
endothelially expressed leukocyte adhesion mediator SELE
displays the second highest fold-change (8.5-fold). SELE has
previously been shown to be up-regulated in wounds from
elderly mice and humans [17]. Moreover, Sele null mice dis-
play reduced local inflammation [18]. We also observed genes
associated with regeneration up-regulated in delayed-healing
wounds, including HOXC6 (embryonic skin patterning; 5.3-
fold) and TWIST1 (involved in liver regeneration; 4.5-fold)
and in this regard it is intriguing that fetal-like regenerative
cutaneous wound repair occurs in the elderly [2]. Insulin deg-
radation in diabetic wounds has been associated with delayed
healing [19] and insulin-degrading enzyme (IDE) is down-
regulated 20-fold in the aged and represented by multiple
probe sets, suggesting that increased insulin may have no det-
rimental effect on wound healing in non-diabetics. Con-
versely, raised insulin levels have been postulated as a
common link in promoting newt limb regeneration [20],
which raises the possibility that this pathway is also involved
in the reduced scarring phenotype observed in the elderly [2].
Many established wound healing genes are altered in wounds
from elderly subjects and are estrogen regulated. Genes with
attenuated expression include the classic pro-healing growth
factor transforming growth factor alpha (TGFA; 8.5-fold
down-regulated), genes linked to chronic wound healing,
such as arginase 1 (ARG1; 82-fold down-regulated), and
genes that when knocked out in mice delay healing, such as
prostaglandin E receptor 3 (PTGER3; 7-fold down-regu-
lated). Such a pronounced reduction in arginase (ARG1)
expression in wounds from aged subjects is particularly inter-
esting. L-arginine, an essential wound healing amino acid, is
converted to nitric oxide, which acts to regulate inflamma-
tion. ARG1 metabolizes L-arginine to generate proline, a sub-
strate for collagen synthesis. Hence, ARG1  is central to
modulating the balance between inflammation and matrix
deposition, an imbalance in which may explain the dramatic
increase in inflammation and decrease in matrix deposition
in the aged.
Aging-associated probe sets within our enriched data set were
identified by interrogation of a publicly available hand-
curated database (the GenAge database) [12] to generate sub-
221728_x_at XIST X (inactive)-specific transcript X chromosome inactivation 2.4E-12 191.8
214218_s_at XIST X (inactive)-specific transcript X chromosome inactivation 1.0E-09 56.2
206211_at SELE selectin E (endothelial adhesion 
molecule 1)
Endothelial-leukocyte adhesion 9.0E-02 8.5
211600_at PTPRO protein tyrosine phosphatase, 
receptor type, O
New marker of podocyte injury 5.0E-04 8.4
220940_at KIAA1641 KIAA1641 Unknown 1.0E-04 8.3
203915_at CXCL9 chemokine (C-X-C motif) ligand 9 Interferon induced, TH1 response 6.3E-02 7.3
204324_s_at GOLPH4 golgi phosphoprotein 4 Protein export 8.3E-04 7.3
201205_at RRBP1 ribosome binding protein 1 homolog 
180 kDa (dog)
Developmentally regulated 
extracellular matrix glycoprotein
6.3E-03 7.3
*Genes in bold have been validated by qPCR. †CyberT-derived multiple testing corrected q-value. ‡Fold change (old/young).
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set S4 (Additional data file 6) or by annotation to known age-
associated processes (heat shock, mitochondria, neurodegen-
eration or response to UV GO groups or by hand annotation)
to generate subset S5 (Additional data file 7). Table 2 shows
differentially expressed aging-associated genes/probe sets
identified in this study, all of which were down-regulated in
wounds from elderly subjects. Only a single identified gene,
HSPA8, is present in the GenAge human aging-related gene
list (out of 243 human genes listed in GenAge; Additional
data file 6). Moreover, not a single gene orthologue from the
model organism GenAge list, which contains 571 genes that
have been demonstrated to directly alter life-span in model
organisms, is present in our enriched data set.
In light of the considerable overrepresentation of estrogen-
regulated genes identified in t h i s  s t u d y ,  w e  n e x t  a s k e d
whether there was statistically significant enrichment for age-
associated genes. Using a binomial distribution we calculate
that, based on the size of the human GenAge database (243
genes), the total number of genes on the U133 array (13,290)
and the total number of genes in our data set (78), we would
expect our enriched data set to contain 1.4 genes from the
GenAge database purely by chance. Hence we observe a sur-
prising, non-statistically significant (p = 0.72) under-repre-
sentation of aging-associated g e n e s .  F o r  t h i s  b i n o m i a l
calculation we have deliberately excluded the much larger list
of GenAge genes shown to modulate lifespan in animal mod-
els, because of obvious orthologue issues. Including the full
GenAge list gave a figure of 3.6 genes expected by chance (p =
0.16). Notably, HSPA8, the gene that we identified as being
present in the GenAge database, is also estrogen-regulated.
Indeed, 76% of the aging-related genes identified in this study
were additionally estrogen-regulated. Hence, it follows that
the most likely candidate genes for mediating intrinsic aging-
associated effects on healing are directly estrogen-regulated.
This observation underpins the key finding of this study,
namely that estrogen-mediated changes in gene expression
are central to age-associated delayed healing.
In an attempt to specifically identify further animal-model
derived putative-human gerontogenes, we relaxed our array
filtering criteria. Filtering for fold change (±1.5-fold), p-value
(<0.05) and expression level (>15) identified 20 genes from
either the human or model organisms GenAge database
Estrogen-regulated wound-healing-associated genes predominate in age-associated delayed healing Figure 2
Estrogen-regulated wound-healing-associated genes predominate in age-associated delayed healing. (a,b) Graphical representation of the relative 
proportions of genes significantly up- (a) or down- (b) regulated in wounds from elderly subjects. (c) The key overrepresented GO groupings (functionally 
conserved gene groups) corresponding to each chart segment, their involvement in cutaneous healing, and significance of over-representation (EASE 
derived p-value). The majority of genes in our enriched data set (Additional data file 1) are estrogen regulated and actively involved in cutaneous healing. 
Ontology groups in red are significantly overrepresented in genes down-regulated in wounds from elderly subjects while those in green are 
overrepresented in genes with increased expression in wounds from elderly subjects.
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(Additional data file 8). Again, this constituted under-repre-
sentation, which in this instance was highly significant (p =
0). Most noticeably we found that every identified putative-
life span modulating gene (i.e., gerontogene) up-regulated in
elderly human wounds acts to extend life-span in animal
models (Additional data file 8). The observed beneficial
effects of these genes in animal models are at odds with the
detrimental nature of delayed human healing, again
reinforcing the lack of importance of gerontogenes in the
process. In contrast, while some down-regulated putative
lifespan modulating genes (i.e., gerontogenes) were associ-
ated with extended lifespan (9 out of 14) others were associ-
ated with reduced lifespan (5 out of 14).
Those genes not regulated by estrogen nor classed as aging-
associated (Table 3) were involved in diverse functions, such
as energy supply and protein catabolism (20% of up-regu-
lated and 11% of down-regulated genes; Figure 2) or were of
unknown function (36% of genes) and could not, therefore,
have been assigned to estrogen or age-associated gene lists.
In order to validate our data, primers were designed to 27 of
the key genes identified in this study and quantitative real-
time PCR (qPCR) carried out on the same wound samples as
used for the arrays and on additional wound samples. In all
cases the real-time findings confirmed the array results (Fig-
ure 3 and data not shown). We then examined the expression
of these genes by qPCR in normal skin and wounds to deter-
mine whether the observed changes were present prior to
wounding or were specifically induced by wounding (Figure 4
and data not shown). Genes fell into two distinct groups seg-
regating depending on estrogen-regulation or age-associa-
tion. All estrogen-regulated genes displayed a statistically
significant difference in expression between wounds from
young and old subjects with a far lower magnitude difference
in normal skin (Figure 4a; for example, LOR), indicating that
the major effects of estrogen are on injured tissue. In contrast,
all age-associated genes displayed pronounced change
between old and young normal skin in addition to, and often
of greater magnitude than, the wound (Figure 4b; for exam-
ple, SDHC), suggesting that age-associated change precedes
the healing response. Whilst this does not preclude such
genes from influencing subsequent healing responses, our
data suggest that not only does estrogen regulate the vast
majority of genes involved in healing, but that the gene pro-
files mimic those seen in wounds from estrogen-deprived
young animals (Figure 5a). Of 14 estrogen-regulated genes
(selected from human subsets S1, S2 and S3), 12 (86%) were
significantly changed in the same direction between human
and mouse (Figure 5a). The remaining genes (PTPRO and
SPRR1A) were also significantly changed in both human and
mouse but in opposite directions. We next tested selected
genes for direct estrogen regulation in vitro (Figure 5d and
data not shown). SELE, which is increased in both old human
and ovx mouse wounds, was down-regulated by estrogen in
vitro, while LYPD3 and ARG1, decreased in both old human
Table 2
Aging-associated probe sets that are differentially expressed in wounds from elderly compared to young subjects
Affy ID Gene* Gene (description) Function q-value† FC‡
Down-regulated probe sets (12)
217496_s_at IDE§ insulin-degrading enzyme Wound fluid/resolution of insulin 
response
4.0E-06 -20.5
210074_at CTSL2§ cathepsin L2 Lysosomal cysteine proteinase 3.8E-05 -15.5
214131_at SERPINB13 serpin peptidase inhibitor, clade B 
(ovalbumin), member 13
UV-responsive proteinase inhibitor 1.1E-03 -15.0
214131_at C12orf5 chromosome 12 open reading frame 
5
Protection from DNA damage 1.1E-03 -12.8
204733_at KLK6§ kallikrein 6 (neurosin, zyme) Hormone regulated serine protease 1.4E-05 -11.9
202179_at BLMH§ bleomycin hydrolase Alzheimer's-associated cysteine 
peptidase
2.1E-03 -11.8
210338_s_at HSPA8§ heat shock 70 kDa protein 8 Aging-associated heat shock protein 9.9E-04 -10.6
201849_at BNIP3§ BCL2/adenovirus E1B 19 kDa 
interacting protein 3
Mitochondrial apoptosis-inducing 2.7E-04 -10.1
203328_x_at IDE§ insulin-degrading enzyme Wound fluid/resolution of insulin 
response
1.4E-05 -17.4
203327_at IDE§ insulin-degrading enzyme Wound fluid/resolution of insulin 
response
7.0E-04 -9.3
205016_at TGFA§ transforming growth factor, alpha IFN-induced/epidermal regeneration 1.0E-03 -8.5
212907_at SLC30A1 Solute carrier family 30 (zinc 
transporter), member 1
Zinc/calcium ion transporter 8.5E-04 -7.3
*Genes in bold have been validated by qPCR. †CyberT-derived multiple testing corrected q-value. ‡Fold change (old/young). §Also estrogen-regulated 
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and ovx mouse wounds, was up-regulated by estrogen.
Changes in gene expression were seen predominantly in mac-
rophages reinforcing the role of inflammation in age-associ-
ated delayed healing.
Moreover, we reasoned that as both mouse groups (intact and
ovx) were of equal age (ten weeks) then genes identified in
human as age-associated should be unchanged upon mouse
comparison. This was confirmed for SLC30A1, a gene identi-
fied as age-associated but not estrogen-regulated in human
(Figure 5b; 1.0-fold), and an additional three genes identified
in human as both age-associated and estrogen-regulated
(Figure 5c; BNIP3, HSPA8 and IDE). Wound expression of all
three genes was not significantly altered between ovx and
intact mice, indicating predominant association with age as
opposed to estrogen status.
We next asked whether observed changes in gene expression
translated into equivalent changes in wound protein levels.
As epidermal genes were most significantly overrepresented
in our enriched human data set we initially focussed on
expression of key epidermal proteins (Figure 6). We selected
the terminal differentiation markers loricrin (-235-fold gene
expression) and involucrin (-8.8-fold gene expression), the
desmosomal cadherin democollin1 (-28.9-fold gene
expression) and the injury-associated intermediate filament
protein keratin16 (-8.3-fold gene expression). In agreement
with gene expression change, both loricrin and involucrin
protein levels were reduced in suprabasal wound epidermis
from elderly human subjects (Figure 6a-d). In addition, the
estrogen-regulation was confirmed at the protein level by
reduced expression of all four proteins in wound epidermis
from ovx female mice compared to intact mice (Figure 6e-l).
The difference in keratin 16 expression between intact and
ovx mouse wounds was particularly striking (compare Figure
6e to 6f). We annotated keratin 16 as estrogen regulated (sub-
set S3; Additional data file 4) based on its inclusion on the
EstrArray custom estrogen-regulated gene microarray [21].
To our knowledge, this study provides the first demonstration
of keratin 16 (KRT16) regulation by estrogen in vivo. Moreo-
ver, a pronounced lack of KRT16 in the wound edge epidermis
from ovx mice is entirely novel and may represent an impor-
tant contributing factor to delayed re-epithelialization, as
keratin 16-mediated re-organization of intermediate fila-
ments in wound edge keratinocytes has been proposed to
facilitate re-epithelialization [22].
We then turned our attention to expression of proteins
encoded by array-identified genes in cells within the granula-
tion tissue of both human and mouse wounds (Figure 7). Pro-
tocadherin 21 (PCDH21), identified in this study as 12-fold
up-regulated at the level of gene expression in wounds from
elderly subjects, but belonging to neither age-associated nor
estrogen-regulated subsets (Table 3), displayed statistically
significant up-regulation in elderly wounds also at the protein
level (Figure 7a,b). Notably, PCDH21 has not previously been
associated with wound healing, aging or estrogen-regulation.
Serpin peptidase inhibitor, clade B (ovalbumin), member 13
Table 3
Non-aging and non-estrogen-associated probe sets that are differentially expressed in wounds from elderly compared to young subjects
Affy ID Gene Gene (description) Function q-value* FC†
Downregulated probe sets (10)
205000_at DDX3Y DEAD (Asp-Glu-Ala-Asp) box 
polypeptide 3, Y-linked
Male fertility-associated RNA 
helicase
5.9E-13 -78.6
217521_at N54942 Transcribed locus Unknown 1.1E-05 -20.1
213780_at TCHH Trichohyalin Hair follicle/cornified envelope 1.0E-02 -13.8
220322_at IL1F9 interleukin 1 family, member 9 Keratinocyte cytokine 9.7E-04 -9.9
218454_at FLJ22662 hypothetical protein FLJ22662 Unknown 1.2E-03 -9.9
218150_at ARL5A ADP-ribosylation factor-like 5A Developmentally regulated nuclear 
protein
1.8E-03 -9.0
205001_s_at DDX3Y DEAD (Asp-Glu-Ala-Asp) box 
polypeptide 3, Y-linked
Male fertility-associated RNA 
helicase
1.1E-05 -8.6
214131_at CYorf15B chromosome Y open reading frame 
15B
X-degenerate gene 1.1E-03 -8.1
203180_at ALDH1A3 Aldehyde dehydrogenase 1 family, 
member A3
Detoxification of aldehydes 7.8E-03 -8.0
207602_at TMPRSS11D transmembrane protease, serine 11D Psoriasis-associated serine protease 2.3E-04 -7.9
Upregulated probe sets (2)
213369_at PCDH21 protocadherin 21 Adhesion 1.3E-05 11.9
221501_x_at LOC339047 hypothetical protein LOC339047 Unknown 9.8E-05 9.3
*CyberT-derived multiple testing corrected q-value. †Fold change (old/young).Genome Biology 2008, 9:R80
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(SERPINB13), identified in this study as age-associated but
not estrogen regulated, and 15-fold down-regulated in
wounds from elderly subjects at the level of expression, was
also reduced in elderly wounds at the protein level (Figure
7c,d).
Another estrogen-regulated gene with a potentially important
role in healing is that encoding arginase 1 (ARG1; 82-fold
down-regulated in wounds from elderly males). We find sig-
nificantly less Arg1 expressing cells in the wound granulation
tissue from ovx mice (Figure 7e,f). While Arg1 is known to be
estrogen regulated in uterus and prostate, it has not previ-
ously been shown to be estrogen regulated in skin. Again, this
novel finding may be important in light of the role of arginase
in modulating the balance between inflammation and matrix
deposition during healing, and in the progression of chronic
wounds [23]. Finally, we returned to Serpinb13 (a gene iden-
tified in this study in human as age-associated but not estro-
gen-regulated) and determined protein levels in wounds from
ovx and intact young female mice. Immunohistochemical
analysis demonstrated that the number of cells expressing
Serpinb13 protein was unaltered by estrogen status in young
female mice (Figure 7g,h), validating this gene as age-associ-
ated but not estrogen-regulated.
Conclusion
Our data clearly implicate estrogen, and not candidate geron-
togenes nor 'age-associated' genes, as the most potent regula-
tor of age-associated delay in human wound healing, a
discovery underscored by the numerous associations between
estrogen-regulated gene polymorphisms and phenotypes
representing aging phenomena, including wound healing
[24,25]. Whilst expression changes in a few genes that appear
to be specifically associated with chronological age were
noted, the majority of these genes were indeed also estrogen
regulated. It is likely, in fact, that there is an intimate relation-
ship between hormones and aging. Recent reports suggest
that the model organism Caenorhabditis elegans contains
several hormonal steroids that can increase lifespan by up to
20%, and that the insulin growth factor/insulin pathway
influences the rate of aging [26,27]. That regulation by estro-
gen at the level of the gene appears to be the most important
mediator of age-related delayed wound healing suggests that
post-transcriptional aging phenomena such as free radical
damage, glycation, and protein error do not play a major role
in this process. We suggest that tissue repair acts as a para-
digm for the effects of estrogen on other age-related patho-
physiological processes, linking estrogen-regulated genes
directly to a protective repair/maintenance program and thus
abating 'aging'.
Validation of array-determined gene expression change by qPCR Figure 3
Validation of array-determined gene expression change by qPCR. Data are represented as fold change (old/young) for array data (blue) and qPCR data 
(pink). Results are presented as mean ± standard error of the mean; n = 3 for arrays and n = 5 for qPCR.
Array qPCR Array qPCR Array qPCR
PTPRO SELE CXCL9
GPX3 BNIP3 CD36
1
2
3
4
5
6
7
8
9
10
1
1.2
1.4
1.6
1.8
2
2.2
2.4
2.6 COL1A1
Array qPCR
-21
-19
-17
-15
-13
-11
-9
-7
-5
-3
-1
-4
-3.5
-3
-2.5
-2
-1.5
-1
PEPI
-15
-13
-11
-9
-7
-5
-3
-1
-21
-19
-17
-15
-13
-11
-9
-7
-5
-3
-1
F
o
l
d
 
c
h
a
n
g
e
F
o
l
d
 
c
h
a
n
g
e
1
3
5
7
9
11
13
1
3
5
7
9
11
13
15http://genomebiology.com/2008/9/5/R80 Genome Biology 2008,     Volume 9, Issue 5, Article R80       Hardman and Ashcroft  R80.11
Genome Biology 2008, 9:R80
Materials and methods
Sample collection and histology
Local ethical committee approval was obtained for all human
studies. Following informed consent eighteen healthy, young
males and nineteen health status-defined elderly males
underwent two 4 mm punch biopsies from the left upper
inner arm after local infiltration with 1 ml of 1% lignocaine.
The first biopsy (normal skin) was followed by re-biopsy of
the same site at one of four pre-defined time points to excise
wound tissue. The selected time points were three days, seven
days, three months and six months post-initial biopsy. Ten-
week-old female C57/Bl6 mice with intact ovaries and ten-
week-old C57/Bl6 mice that had undergone ovariectomy one
month previously were anesthetized and wounded following
our established protocol [9] (in accordance with home office
regulations). Briefly, two equidistant 1 cm full-thickness skin
incisional wounds were made through both skin and
panniculus carnosus muscle, and left to heal by secondary
intention. Wounds were excised and bisected at day 3 after
wounding, with one-half of the sample processed for
histology.
Histological sections were prepared from biopsy/mouse
wound tissue fixed in 10% buffered formalin and embedded
in paraffin. Sections (5 μm) were stained with hematoxylin
and eosin, or subjected to immunohistochemistry with mouse
monoclonal anti-CD15 (BD Biosciences, Pharmingen,
Oxford, UK), mouse monoclonal anti-CD68, anti-VWF
(Dako, Cambridge, UK), anti-MIF goat polyclonal antibody
(R&D Systems, Abingdon, UK), anti-LOR, anti-INV (Cov-
ance, Berkeley, CA, USA), JCMC (rabbit polyclonal anti-
Dsc1), anti-K16, anti-ARG1 (Santa Cruz Biotechnology, Santa
Cruz, CA, USA), anti-PCDH21 or anti-SERPINB13 (Abcam,
Cambridge, UK) and the appropriate biotinylated secondary
antibody followed by ABC-peroxidase reagent (Vector Labo-
ratories, Peterborough, UK) with Novared substrate and
Quantification of gene expression change by qPCR Figure 4
Quantification of gene expression change by qPCR. Comparison of gene expression between normal skin (NS) and wounds (W) from young (pink) and old 
(blue) human subjects. (a) All estrogen-regulated genes tested displayed clear differential wound expression (red double-ended arrow) with more parity of 
expression in normal skin. (b) In contrast, genes identified as age-associated displayed pronounced changes in normal skin (blue double-ended arrow) of 
similar or greater magnitude than the wound gene expression change. n = 3-5 per group.
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Gene expression nges identified in aged males are mirrored in ovx female mice Figure 5
Gene expression changes identified in aged males are mirrored in ovx female mice. (a,b) Comparison of wound gene expression change between human 
males (old/young; left) and estrogen-deprived young female mice (ovx/intact; right). Arrows indicate direction of change, green up and red down. (a) 
Estrogen-regulated genes are similarly changed in both mouse and human. (b) In contrast, a gene identified as age-associated is unchanged in wounds from 
ovx female mice. (c) Genes categorized as both estrogen-regulated and age-associated were either unchanged in mouse (indicating predominant age-
association) or similarly changed in both mouse and human (indicating predominant estrogen-regulation). (d) Demonstration that selected array-identified 
genes are directly estrogen regulated in mouse primary macrophages and/or fibroblasts in vitro. Results are presented as mean ± standard error of the 
mean; n = 3-6 per group.
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counterstaining with hematoxylin. Control slides stained with
secondary antibody in isolation or control IgG were negative.
Total cell numbers and re-epithelialization were quantified
with Image Pro Plus software as previously described [8]
(MediaCybernetics, Silver Spring, MD, USA).
Sample collection and RNA preparation
Following informed consent, five healthy, young males (24-
27 years old) and five health status-defined elderly males (71-
76 years old) underwent two 4 mm punch biopsies from the
left upper inner arm after local infiltration with 1 ml of 1%
lignocaine. The first biopsy (normal skin) was followed by re-
biopsy of the same site seven days later to excise wound tis-
sue. In addition, ten-week-old female BALB/c mice with
intact ovaries and ten-week-old mice that had undergone
ovariectomy one month previously were anesthetized and
wounded following our established protocol [9] (in accord-
ance with home office regulations). Wounds were excised and
bisected three days after wounding, and one-half of the
wound was flash frozen at -80°C before RNA extraction. Total
RNA was isolated from frozen tissue by homogenizing in Tri-
zol reagent (Invitrogen, Paisley, UK) following the manufac-
turer's instructions.
Immunohistochemical analysis of epidermal proteins encoded by array-identified estrogen-regulated genes demonstrates altered expression in wounds  from both old humans and ovx young female mice Figure 6
Immunohistochemical analysis of epidermal proteins encoded by array-identified estrogen-regulated genes demonstrates altered expression in wounds 
from both old humans and ovx young female mice. (a-d) Representative immunohistochemical localization of the epidermal differentiation markers 
loricrin and involucrin demonstrates decreased expression in wound epidermis from old males compared to wounds from young males. (e-l) 
Representative immunohistochemical localization of the epidermal proteins keratin 16, loricrin, involucrin and desmocollin 1, which are decreased in 
wound epidermis from young ovx mice compared to wounds from mice with intact ovaries. The scale bar in (l) represents 70 μm (a-d), 300 μm (e-f), and 
140 μm (g-j).
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Immunohistochemical analysis of proteins encoded by array-identified dermally expressed genes during human and murine wound healing Figure 7
Immunohistochemical analysis of proteins encoded by array-identified dermally expressed genes during human and murine wound healing. (a-d) In 
agreement with array findings, human wound granulation tissue protein levels of Protocadherin 21 (a) and SERPINB13 protein (b) mirrors changes in gene 
expression. (e,f) In mice, the number of granulation tissue cells expressing arginase 1 is reduced in wounds from ovx mice, mirroring the human array 
findings and validating this gene/protein as estrogen regulated. (g,h) In contrast, yet also in agreement with human array findings, the number of 
granulation tissue cells expressing serpinb13 was not significantly altered between intact and ovx mice, that is, not dependent on estrogen levels. Results 
are presented as mean ± standard error of the mean; *p < 0.05. The scale bar in (h) represents 45 μm (b,d), 20 μm (f) and 35 μm (h); n = 3-6 per group.
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Cell culture
Mouse peritoneal macrophages were isolated by intraperito-
neal lavage with ice-cold sterile phosphate-buffered saline,
pooled for subsequent studies and cell viability determined by
trypan blue. Cells were re-suspended at a concentration of 106
cells per ml in serum-free phenol-red free Dulbecco's modi-
fied Eagle's medium (DMEM) medium, treated with lipopol-
ysaccharide (1 mg/ml) and 10-7  or 10-8 M 17-β-estradiol
(Sigma-Aldrich, St Louis, MO, USA) or lipopolysaccharide
alone. Cells were washed, 0.5 ml TRIzol (Invitrogen Corp.,
Carlsbad, CA, USA) was added per well, and plates were
stored at -80°C before RNA extraction. Mouse dermal fibrob-
lasts were isolated as follows. Epidermis and dermis were
separated following overnight incubation in 0.25% Trypsin/
EDTA (Cascade Biologics, Portland, OR, USA) at 4°C. Minced
dermis was incubated in 0.3% collagenase in DMEM for 30
minutes at 37°C in 5% CO2 atmosphere with regular agitation.
The collagenase-cell mixture was filtered, centrifuged, and
isolated fibroblasts washed with fresh media (DMEM, 5%
fetal calf serum, L-glutamine, 1% Penicillin, Streptomycin,
and Amphotericin B (PSA) prior to plating. Cells were plated
and cultured until confluent in DMEM medium supple-
mented with Penicillin/Streptomycin and 10% charcoal-
stripped fetal calf serum (Thermo Scientific, Waltham, MA,
USA). Confluent fibroblasts were treated with lipopolysac-
charide (1 mg/ml) and 10-8 or 10-9 M 17-β-estradiol (Sigma-
Aldrich) or lipopolysaccharide alone. Cells were washed, 0.5
ml TRIzol (Invitrogen Corp.) was added per well, and plates
were stored at -80°C before RNA extraction.
Microarray analysis
Human microarray experiments were performed using the
human genome U133A oligonucleotide array (Affymetrix
Inc., High Wycombe, UK) according to the manufacturer's
instructions. Total wound RNA (100 ng) from three old and
three young male subjects was used with the Two-Cycle cDNA
Synthesis Kit (P/N 900432 Affymetrix Inc.; one sample
hybridized per array). Technical quality control was per-
formed with dChip [28]. Background correction, quantile
normalization, and gene expression analysis were performed
using GCRMA [29]. The microarray data were submitted in
MIAME (minimum information about a microarray experi-
ment)-compliant format to the ArrayExpress database [30].
Differential expression between the young and old groups
was tested statistically with CyberT on logarithmic scale data
[31]. False-discovery correction was performed with Q-value
software [32]. Significantly changed probe sets were selected
on fold change (±7-fold), q-value (<0.1) and expression level
(>15) (see Additional data file 1 for a full list). For up- and
down-regulated gene data sets overrepresented GO groups
were identified using the second generation (DAVID 2007)
expression analysis systematic explorer (EASE) online func-
tional annotation tool [33] (Additional data file 5). Mouse
microarray experiments were performed as previously
described [9], ArrayExpress database accession number e-
mexp-209. Briefly, biotinylated cRNA samples from
individual intact and ovx mice were hybridized to mouse
430A oligonucleotide arrays (Affymetrix Inc., Santa Clara,
CA, USA). For this current experiment data were re-analyzed
using GCRMA for background correction, quantile normali-
zation, and gene expression analysis [29]. Differential expres-
sion between the intact and ovx groups was tested statistically
with CyberT on logarithmic scale data [31]. Significantly
changed probe sets were selected on fold change (±1.5-fold),
p-value (<0.1) and expression level (>50).
Hormonally regulated genes were identified by: comparison
of significantly changed human probesets (Additional data
file 1) with the Dragon online database of estrogen regulated
genes [11] to generate conserved gene subset S1 (Additional
data file 2); cross-species comparison of human genes identi-
f i e d  i n  t h i s  s t u d y  ( U 1 3 3 A  m i c r o a r r a y s )  w i t h  g e n e s  u p -  o r
down-regulated in hormonally mediated delayed-healing
murine wounds (430A microarrays) to generate conserved
gene subset S2 (Additional data file 3); and hand annotation
as estrogen-regulated following an exhaustive literature
search to generate conserved gene subset S3 (Additional data
file 4). Aging-associated genes were identified using: compar-
ison of significantly changed human probesets (Additional
data file 1) with the hand curated GenAge database of aging-
associated genes [12] to generate conserved gene subset S4
(Additional data file 6); combined with genes annotated with
known age-associated ontology groups (DNA damage,
mitochondria, neurodegeneration or response to UV) and/or
hand annotated as age-associated following an exhaustive lit-
erature search to generate conserved gene subset S5 (Addi-
tional data file 7).
qPCR and comparison with microarrays
cDNA was transcribed from 0.5 μg of human wound RNA
(five old and five young male subjects), from 0.5 μg of human
normal skin RNA (three old and three young subjects), from
1 μg of mouse wound RNA (six intact and six oxv mice) and 1
μg of RNA isolated from estrogen-treated macrophages or
fibrolasts. (Promega RT kit and AMV-reverse transcriptase;
Roche, Welwyn Garden City, UK). Primer sequences were
designed to each gene coding sequence independently of the
Affymetrix probe set target region sequence and hence may or
may not be directed to the same gene region. qPCR was
performed using the SYBR green core kit (Eurogentec, South-
ampton, UK) following the manufacturer's instructions and
an Opticon qPCR thermal cycler (Bio-Rad, Hemel
Hempstead, UK). For each primer set an optimal dilution was
determined, and melting curves were used to determine
product specificity. Each sample was serially diluted over
three orders of magnitude, and for each primer set all samples
were run on the same 96-well plate. For primer sequences see
Additional data file 9. Expression ratios were determined rel-
ative to a standard sample and normalized using a value
derived from three separate control primer sets to 18s rRNA
and the housekeeping genes Gapdh and Ywahz. In Figure 4,
fold change is presented relative to young normal skin withGenome Biology 2008, 9:R80
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values below 1 converted to negative fold change. In Figure 5,
data for estrogen treated cells is presented as fold change rel-
ative to each cell type treated with lipopolysaccharide alone
with values below 1 again converted to negative fold change.
Data deposition
Microarray data have been deposited in MIAME compliant
format in the ArrayExpress database [34], accession number
E-MEXP-1074.
Abbreviations
DMEM, Dulbecco's modified Eagle's medium; EASE, expres-
sion analysis systematic explorer; GO, gene ontology;
MIAME, minimum information about a microarray
experiment; ovx, ovariectomised; qPCR, quantitative real-
time PCR.
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The following additional data are available. Additional data
file 1 is a table listing all probe sets identified as differentially
expressed using the filtering criteria fold change (±7-fold), q-
value (<0.1) and expression level (>15). Additional data file 2
is a table listing the full subset S1 - Dragon database-derived
estrogen-regulated probe sets. Additional data file 3 is a table
listing the full subset S2 - mouse dataset-derived estrogen-
regulated probe sets. Additional data file 4 is a table listing the
full subset S3 - hand-annotated estrogen-regulated probe
sets. Additional data file 5 is a table listing the full EASE
experimental readout. Additional data file 6 is a table listing
the full subset S4 - GenAge-derived aging-associated probe
sets. Additional data file 7 is a table listing the full subset S5 -
hand-curated and aging-associated GO probe sets. Additional
data file 8 is a table listing differentially expressed genes iden-
tified in this study, using a relaxed array filtering criteria, that
have also been demonstrated to alter life-span in animal
models. Additional data file 9 is a table listing all primers used
for qPCR.
Additional data file 1 All probe sets identified as differentially expressed using the filter- ing criteria fold change (±7-fold), q-value (<0.1) and expression  level (>15) All probe sets identified as differentially expressed using the filter- ing criteria fold change (±7-fold), q-value (<0.1) and expression  level (>15). Click here for file Additional data file 2 Subset S1: Dragon database-derived estrogen-regulated probe sets Subset S1: Dragon database-derived estrogen-regulated probe sets. Click here for file Additional data file 3 Subset S2: mouse dataset-derived estrogen-regulated probe sets Subset S2: mouse dataset-derived estrogen-regulated probe sets. Click here for file Additional data file 4 Subset S3: hand-annotated estrogen-regulated probe sets Subset S3: hand-annotated estrogen-regulated probe sets. Click here for file Additional data file 5 EASE experimental readout EASE experimental readout. Click here for file Additional data file 6 Subset S4: GenAge-derived aging-associated probe sets Subset S4: GenAge-derived aging-associated probe sets. Click here for file Additional data file 7 Subset S5: hand-curated and aging-associated GO probe sets Subset S5: hand-curated and aging-associated GO probe sets. Click here for file Additional data file 8 Differentially expressed genes identified in this study, using a  relaxed array filtering criteria, that have also been demonstrated to  alter life-span in animal models Differentially expressed genes identified in this study, using a  relaxed array filtering criteria, that have also been demonstrated to  alter life-span in animal models. Click here for file Additional data file 9 Primers used for qPCR Primers used for qPCR. Click here for file
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